Lipoprotein(a) in patients with carotid atherosclerosis and ischemic cerebrovascular disorders.
The aim of this study was to evaluate the role of lipoprotein(a) in the carotid atherosclerosis and ischemic cerebrovascular disorders. Four groups of subjects were included: 49 patients with transient ischemic attacks, 61 with acute cerebral infarction, 48 with asymptomatic carotid atherosclerosis and a group of 50 healthy subjects. Lipoprotein(a) serum concentration and its correlation with various clinical parameters was analysed. The results revealed a significant difference between lipoprotein(a) serum levels in patients and healthy subjects and positive correlation between lipoprotein(a) serum levels and the degree of carotid atherosclerosis. Moreover, some other correlations are found and discussed. It was concluded that lipoprotein(a) is involved in the pathogenesis of carotid atherosclerosis, but it is not associated with the development of ischemic cerebrovascular disorders.
Jovicic
A
A
Clinic of Neurology, Military Medical Academy, Belgrade, Yugoslavia.
Ivanisevic
V
V
Ivanovic
I
I
D001161:Arteriosclerosis / Q000097:blood* / Q000503:physiopathology; D001794:Blood Pressure; D002340:Carotid Artery Diseases / Q000097:blood* / Q000503:physiopathology; D002544:Cerebral Infarction / Q000097:blood* / Q000503:physiopathology; D006801:Humans; D002546:Ischemic Attack, Transient / Q000097:blood* / Q000503:physiopathology; D017270:Lipoprotein(a) / Q000097:blood*; D008297:Male; D008875:Middle Aged; D012907:Smoking
D017270:Lipoprotein(a)